Description

Vitamin D Deficiency Diagnostic Assay Market Outline

Vitamin D is a steroidal hormone that requires multiple metabolic steps to become active and useful in human body. Vitamin D can be found in several sources such as fish, eggs and sunlight.  Vitamin D deficiency causes rickets in children and will precipitate and exacerbate osteopenia, osteoporosis and fractures in adults. Vitamin D deficiency has been associated with increased risk of common cancers, autoimmune diseases, hypertension and infectious diseases.

 

Vitamin D Deficiency Diagnostic Assay Market Dynamics

Increase in geriatric population coupled with increase in chronic illnesses, rising risk inn development of vitamin D deficiency includes pregnant and breast feeding women, teenagers, infants and children are anticipated to drive the market growth of vitamin d deficiency diagnostic assay market globally. Moreover, growing investments on R&D activities, approval and commercialization of new tests, geographical expansions by the market players and initiatives taken by the governments also propels the market growth of vitamin d deficiency diagnostic assay. However, unavailability of the tests in some regions, dearth of skilled workforce, lack of awareness regarding the tests and high cost associated with the diagnosis may hinder the growth the vitamin d deficiency diagnostic assay market.

 

Market Scope: 

Vitamin D Deficiency Diagnostic Assay market is segmented based on the type, end user and geographical regions

Based on the type, market is segmented into the following

  • 1, 25-Dihydroxy Vitamin D Test
  • 25-Hydroxy Vitamin D Test

Based on the end user, market is segmented into the following

  • Hospitals
  • Research Centers
  • Diagnostic Centers

Based on the geographical regions, market is segmented into the following

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

 

Market Summary: 

Vitamin D is known for its role in mineralization of teeth and bones through regulation of calcium and phosphorous hemostasis. Recently, there is emerging evidence of role of vitamin D in protection against risk for malignant neoplasms, cardiac diseases, diabetes along with osteoporosis and other bone disorders.  Vitamin d deficiency diagnostic assay market is saturated with many number of market players, hence companies are focusing on strategic such as agreements, partnerships, collaborations to survive in the market. Companies are also actively concentrating on collaborations with the governments, hospitals and research laboratories to raise funds for development of advanced products. For example, in 2014 Roche invested 450 Mn to build a new diagnostic equipment manufacturing unit in china and expected to commence the operation in 2018 to capture the market in Asia Pacific especially in China.

 

Regional Analysis: 

Geographically, global Vitamin D Deficiency Diagnostic Assay market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North merica hold the largest position owing to the high awareness about Vitamin D diagnosis assay, high healthcare, presence of many local players. Europe market is dominated by Germany, Italy and France due easy availability of products, well established healthcare infrastructure, latest approvals of the tests and investments by the government and companies. For Instance, In 2017, Future diagnostics and DIA source received a grant of 1.4Mn Euros from European Commission to develop a unique CE-market assay that can measure the level of free vitamin D in the body. Asia Pacific is projected to witness a substantial growth due to rise in investments by several market players in APAC region, growing healthcare expenditure etc.

 

Competition Assessment:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • DiaSorin S.p.A. (Italy)
  • Abbott Laboratories (U.S.)
  • Siemens Corporation (Germany)
  • Hologic, Inc, (U.S)
  • Quest Diagnostics, Inc. (U.S)
  • Danaher Corporation (U.S.)
  • bioMérieux SA (France)

 

Notable market developments: 

  • In January 2017, Beckman Coulter Diagnostics received 510(k) clearance from U.S.FDA  for the Access 25(OH) Vitamin D Total assay

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX